Cargando…
Ischaemic stroke in the absence of documented atrial fibrillation: is there who could benefit from anticoagulant therapy?
About 25% of ischaemic strokes are of cryptogenic origin and a significant proportion of them has a certain embolic nature, and for these patients the term embolic stroke of undetermined source (ESUS) has been coined. In the absence of subclinical atrial fibrillation (AF) identifiable through prolon...
Autores principales: | Vassiliki’ Coutsoumbas, Gloria, Di Pasquale, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653157/ https://www.ncbi.nlm.nih.gov/pubmed/36380787 http://dx.doi.org/10.1093/eurheartjsupp/suac079 |
Ejemplares similares
-
Therapeutic uncertainties: first finding of atrial fibrillation in acute coronary syndrome
por: Greco, Antonio, et al.
Publicado: (2022) -
An aggressive solution for patients with heart failure and atrial fibrillation: nodal ablation and cardiac resynchronization therapy
por: Bianchi, Stefano, et al.
Publicado: (2022) -
When to set anticoagulant therapy in asymptomatic AF? looking for a cut-off duration
por: Rossini, Roberta, et al.
Publicado: (2022) -
What is the role of coronary revascularization to recover the contractility of the dysfunctional heart?
por: Vassiliki’ Cousoumbas, Gloria, et al.
Publicado: (2023) -
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)